Literature DB >> 19230913

Long-term outcome of simultaneous transurethral resection of bladder tumor and prostate in patients with nonmuscle invasive bladder tumor and bladder outlet obstruction.

Won Sik Ham1, Won Tae Kim, Hyung Jin Jeon, Dong Hoon Lee, Young Deuk Choi.   

Abstract

PURPOSE: We evaluated the long-term outcome of simultaneous transurethral bladder tumor and prostate resection in patients with nonmuscle invasive bladder tumor and bladder outlet obstruction.
MATERIALS AND METHODS: Between April 1997 and April 2006, 213 patients with nonmuscle invasive bladder tumor who had a minimum followup of 24 months were included in the study, including group 1-107 with transurethral resection of bladder tumor only and group 2-106 with transurethral bladder tumor and prostate resection. Simultaneous transurethral bladder tumor and prostate resection was performed at surgeon discretion. The records were retrospectively analyzed for clinicopathological parameters, recurrence and progression rates, time to recurrence and postoperative uroflowmetry results in the 2 groups.
RESULTS: There were no significant differences in clinicopathological parameters between the 2 groups. At a mean followup of 54.3 and 50.1 months in groups 1 and 2, respectively, group 2 patients with a tumor less than 3 cm or a single tumor had a significantly lower recurrence rate than group 1 patients. None of the 31 patients with recurrence in group 2 had recurrence in the bladder neck or prostatic urethra where transurethral prostate resection had been done. There was no significant difference in the progression rate between the 2 groups. The 60-month recurrence-free probability in groups 1 and 2 was 43.4% and 52.0%, respectively. Three months after surgery the postvoid residual urine volume had significantly decreased in group 2.
CONCLUSIONS: Simultaneous transurethral bladder tumor and prostate resection may help decrease bladder cancer recurrence and delay time to recurrence without the risk of cancer implantation when transurethral prostate resection is done, especially in patients with a papillary, solitary-appearing bladder lesion less than 3 cm.

Entities:  

Mesh:

Year:  2009        PMID: 19230913     DOI: 10.1016/j.juro.2008.11.099

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Is it oncologically safe performing simultaneous transurethral resection of the bladder and prostate? A meta-analysis on 1,234 patients.

Authors:  Stefano C M Picozzi; Cristian Ricci; Maddalena Gaeta; Stefano Casellato; Giorgio Bozzini; Dario Ratti; Luca Carmignani
Journal:  Int Urol Nephrol       Date:  2012-06-19       Impact factor: 2.370

2.  Bladder lesions as incidental findings during transurethral resection of the prostate: prevalence, diagnosis, and pathological findings.

Authors:  Rafael de Cunto Romero; Wagner A Franca; Cristiane B Dias; Conrado G Pascini; Estevão C Amin; Luis A S Rios
Journal:  World J Urol       Date:  2020-07-30       Impact factor: 4.226

3.  Oncological safety and quality of life in men undergoing simultaneous transurethral resection of bladder tumor and prostate: results from a randomized controlled trial.

Authors:  Marco Dellabella; Alessandro Branchi; Luca Gasparri; Redi Claudini; Daniele Castellani
Journal:  World J Urol       Date:  2018-05-03       Impact factor: 4.226

4.  Moderate or severe LUTS is associated with increased recurrence of non - muscle - invasive urothelial carcinoma of the bladder.

Authors:  Austin Lunney; Allan Haynes; Pranav Sharma
Journal:  Int Braz J Urol       Date:  2019 Mar-Apr       Impact factor: 1.541

Review 5.  The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta-analysis.

Authors:  Reza Sari Motlagh; Keiichiro Mori; Noriyoshi Miura; Fahad Quhal; Abdulmajeed Aydh; Ekaterina Laukhtina; Benjamin Pradere; Pierre I Karakiewicz; Dmitry V Enikeev; Marina Deuker; Shahrokh F Shariat
Journal:  BJU Int       Date:  2020-08-12       Impact factor: 5.588

6.  Prognostic value of prostate volume in non-muscle invasive bladder cancer.

Authors:  Won Sik Ham; Jee Soo Park; Won Sik Jang; Young Deuk Choi; Jongchan Kim
Journal:  Sci Rep       Date:  2021-09-22       Impact factor: 4.379

7.  Simultaneous transurethral resection of bladder cancer and prostate may reduce recurrence rates: A systematic review and meta-analysis.

Authors:  Sheng Li; Xian-Tao Zeng; Xiao-Lan Ruan; Xing-Huan Wang; Yi Guo; Zhong-Hua Yang
Journal:  Exp Ther Med       Date:  2012-08-09       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.